International Journal of Cancer Management

Published by: Kowsar

The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review

Reza Shekarriz-Foumani 1 and Faezeh Khodaie 1 , *
Authors Information
1 Department of Community Medicine, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Iranian Journal of Cancer Prevention: June 2016, 9 (3); e4469
  • Published Online: April 24, 2016
  • Article Type: Review Article
  • Received: November 5, 2015
  • Accepted: March 14, 2016
  • DOI: 10.17795/ijcp-4469

To Cite: Shekarriz-Foumani R, Khodaie F. The Correlation of Plasma 25-Hydroxyvitamin D Deficiency With Risk of Breast Neoplasms: A Systematic Review, Int J Cancer Manag. 2016 ; 9(3):e4469. doi: 10.17795/ijcp-4469.

Abstract
Copyright © 2016, Iranian Journal of Cancer Prevention. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Context
2. Objectives
3. Data Sources
4. Study Selection
5. Data Extraction
6. Results
7. Discussion
Acknowledgements
Footnotes
References
  • 1. Global Burden of Disease Cancer C, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, et al. The Global Burden of Cancer 2013. JAMA Oncol. 2015; 1(4): 505-27[DOI][PubMed]
  • 2. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3): 266-81[DOI][PubMed]
  • 3. Meems LM, de Borst MH, Postma DS, Vonk JM, Kremer HP, Schuttelaar ML, et al. Low levels of vitamin D are associated with multimorbidity: results from the LifeLines Cohort Study. Ann Med. 2015; 47(6): 474-81[DOI][PubMed]
  • 4. Pludowski P, Holick MF, Pilz S, Wagner CL, Hollis BW, Grant WB, et al. Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmun Rev. 2013; 12(10): 976-89[DOI][PubMed]
  • 5. Obaidi J, Musallam E, Al-Ghzawi HM, Azzeghaiby SN, Alzoghaibi IN. Vitamin D and its relationship with breast cancer: an evidence based practice paper. Glob J Health Sci. 2015; 7(1): 261-6[DOI][PubMed]
  • 6. Wang J, Eliassen AH, Spiegelman D, Willett WC, Hankinson SE. Plasma free 25-hydroxyvitamin D, vitamin D binding protein, and risk of breast cancer in the Nurses' Health Study II. Cancer Causes Control. 2014; 25(7): 819-27[DOI][PubMed]
  • 7. Alco G, Igdem S, Dincer M, Ozmen V, Saglam S, Selamoglu D, et al. Vitamin D levels in patients with breast cancer: importance of dressing style. Asian Pac J Cancer Prev. 2014; 15(3): 1357-62[PubMed]
  • 8. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int. 2009; 20(11): 1807-20[DOI][PubMed]
  • 9. Henry HL. Regulation of vitamin D metabolism. Best Pract Res Clin Endocrinol Metab. 2011; 25(4): 531-41[DOI][PubMed]
  • 10. Racz A, Barsony J. Hormone-dependent translocation of vitamin D receptors is linked to transactivation. J Biol Chem. 1999; 274(27): 19352-60[PubMed]
  • 11. Tagliabue E, Raimondi S, Gandini S. Vitamin D, Cancer Risk, and Mortality. Adv Food Nutr Res. 2015; 75: 1-52[DOI][PubMed]
  • 12. de Lyra EC, da Silva IA, Katayama ML, Brentani MM, Nonogaki S, Goes JC, et al. 25(OH)D3 and 1,25(OH)2D3 serum concentration and breast tissue expression of 1alpha-hydroxylase, 24-hydroxylase and Vitamin D receptor in women with and without breast cancer. J Steroid Biochem Mol Biol. 2006; 100(4-5): 184-92[DOI][PubMed]
  • 13. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health. 2006; 96(2): 252-61[DOI][PubMed]
  • 14. Ness RA, Miller DD, Li W. The role of vitamin D in cancer prevention. Chin J Nat Med. 2015; 13(7): 481-97[DOI][PubMed]
  • 15. Holick MF. Vitamin D: its role in cancer prevention and treatment. Prog Biophys Mol Biol. 2006; 92(1): 49-59[DOI][PubMed]
  • 16. Touvier M, Chan DS, Lau R, Aune D, Vieira R, Greenwood DC, et al. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011; 20(5): 1003-16[DOI][PubMed]
  • 17. Mun MJ, Kim TH, Hwang JY, Jang WC. Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis. Maturitas. 2015; 81(2): 256-65[DOI][PubMed]
  • 18. Johnson AL, Zinser GM, Waltz SE. Vitamin D3-dependent VDR signaling delays ron-mediated breast tumorigenesis through suppression of beta-catenin activity. Oncotarget. 2015; 6(18): 16304-20[DOI][PubMed]
  • 19. Garland CF, Gorham ED, Mohr SB, Garland FC. Vitamin D for cancer prevention: global perspective. Ann Epidemiol. 2009; 19(7): 468-83[DOI][PubMed]
  • 20. Boeke CE, Tamimi RM, Berkey CS, Colditz GA, Giovannucci E, Malspeis S, et al. Adolescent dietary vitamin D and sun exposure in relation to benign breast disease. Cancer Causes Control. 2015; 26(8): 1181-7[DOI][PubMed]
  • 21. Moher D, Liberati A, Tetzlaff J, Altman DG, Prisma Group . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009; 62(10): 1006-12[DOI][PubMed]
  • 22. Bertrand KA, Rosner B, Eliassen AH, Hankinson SE, Rexrode KM, Willett W, et al. Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer. Breast Cancer Res Treat. 2015; 149(2): 479-87[DOI][PubMed]
  • 23. Reimers LL, Crew KD, Bradshaw PT, Santella RM, Steck SE, Sirosh I, et al. Vitamin D-related gene polymorphisms, plasma 25-hydroxyvitamin D, and breast cancer risk. Cancer Causes Control. 2015; 26(2): 187-203[DOI][PubMed]
  • 24. Kim Y, Franke AA, Shvetsov YB, Wilkens LR, Cooney RV, Lurie G, et al. Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer. 2014; 14: 29[DOI][PubMed]
  • 25. Colagar AH, Firouzjah HM, Halalkhor S. Vitamin D Receptor Poly(A) Microsatellite Polymorphism and 25-Hydroxyvitamin D Serum Levels: Association with Susceptibility to Breast Cancer. J Breast Cancer. 2015; 18(2): 119-25[DOI][PubMed]
  • 26. Alipour S, Hadji M, Hosseini L, Omranipour R, Saberi A, Seifollahi A, et al. Levels of serum 25-hydroxy-vitamin d in benign and malignant breast masses. Asian Pac J Cancer Prev. 2014; 15(1): 129-32[PubMed]
  • 27. Abdelgawad IA, El-Mously RH, Saber MM, Mansour OA, Shouman SA. Significance of serum levels of vitamin D and some related minerals in breast cancer patients. Int J Clin Exp Pathol. 2015; 8(4): 4074-82[PubMed]
  • 28. Thanasitthichai S, Chaiwerawattana A, Prasitthipayong A. Association of Vitamin D Level with Clinicopathological Features in Breast Cancer. Asian Pac J Cancer Prev. 2015; 16(12): 4881-3[PubMed]
  • 29. Park S, Lee DH, Jeon JY, Ryu J, Kim S, Kim JY, et al. Serum 25-hydroxyvitamin D deficiency and increased risk of breast cancer among Korean women: a case-control study. Breast Cancer Res Treat. 2015; 152(1): 147-54[DOI][PubMed]
  • 30. Imtiaz S, Siddiqui N. Vitamin-D status at breast cancer diagnosis: correlation with social and environmental factors and dietary intake. J Ayub Med Coll Abbottabad. 2014; 26(2): 186-90[PubMed]
  • 31. Shi L, Nechuta S, Gao YT, Zheng Y, Dorjgochoo T, Wu J, et al. Correlates of 25-hydroxyvitamin D among Chinese breast cancer patients. PLoS One. 2014; 9(1)[DOI][PubMed]
  • 32. Bidgoli SA, Azarshab H. Role of vitamin D deficiency and lack of sun exposure in the incidence of premenopausal breast cancer: a case control study in Sabzevar, Iran. Asian Pac J Cancer Prev. 2014; 15(8): 3391-6[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments